Why the study?
Broader adoption of continuous glucose monitoring systems is limited by cost and invasiveness, as current devices require implantation or hypodermic needles.
Does magnetohydrodynamics (MHD) provide accurate needle-free continuous glucose monitoring compared to capillary blood glucose in healthy volunteers?
Does magnetohydrodynamics (MHD) provide accurate needle-free continuous glucose monitoring compared to capillary blood glucose in healthy volunteers?
Magnetohydrodynamics (MHD) shows promise as a needle-free method for continuous glucose monitoring, achieving a MARD of 12.9% in a pilot study of healthy volunteers.
MHD enables needle-free dermal ISF extraction; leaves open accuracy, reliability, and clinical utility pending larger trials.
The benefits of continuous glucose monitoring (CGM) in diabetes management are extensively documented. Yet, the broader adoption of CGM systems is limited by their cost and invasiveness. Current CGM devices, requiring implantation or the use of hypodermic needles, fail to offer a convenient solution. We have demonstrated that magnetohydrodynamics (MHD) is effective at extracting dermal interstitial fluid (ISF) containing glucose, without the use of needles. Here we present the first study of ISF sampling with MHD for glucose monitoring in humans. We conducted 10 glucose tolerance tests on 5 healthy volunteers and obtained a significant correlation between the concentration of glucose in ISF samples extracted with MHD and capillary blood glucose samples. Upon calibration and time lag removal, the data indicate a Mean Absolute Relative Difference (MARD) of 12.9% and Precision Absolute Relative Difference of 13.1%. In view of these results, we discuss the potential value and limitations of MHD in needle-free glucose monitoring.
No takes yet. Share an insight, caveat, or question.
Hakala et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: